On January 26, 2026, Genyro Inc., an early-stage, California-based biotechnology company advancing next-generation DNA construction, announced that it has entered into an exclusive licensing agreement with the California Institute of Technology (Caltech) for Sidewinder™, a breakthrough DNA construction invention recently featured in Nature. Wilson Sonsini Goodrich & Rosati advises Genyro on IP and corporate matters and represented the company in the licensing agreement with Caltech.

Sidewinder represents the first DNA construction technology based on DNA 3-Way Junctions (3WJ), enabling the accurate construction of long, complex, and highly repetitive DNA sequences that have historically been challenging to build. The technology was developed by Professor Kaihang Wang, tenure-track assistant professor of biology and biological engineering at Caltech and co-founder and chief scientific advisor at Genyro. It is the first DNA construction method to separate the sequence information of the final assembled DNA product from the information guiding its assembly.

The Wilson Sonsini team advising Genyro includes Karen Deschaine, Lou Lieto, and Nellie Brutocao.

For more information, please see Genyro’s news release. Additional coverage of Genyro is available in The Times and Endpoints News.